Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Dermatitis, Contact

paclitaxel has been researched along with Dermatitis, Contact in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domb, AJ; Krasko, MY; Nyska, A; Shikanov, A; Vaisman, B1
Adamo, DO; Christian, MC; Davis, P; Kohn, EC; Link, CJ; Reed, E; Sarosy, GA1

Other Studies

2 other study(ies) available for paclitaxel and Dermatitis, Contact

ArticleYear
Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity.
    Journal of biomedical materials research. Part A, 2004, Apr-01, Volume: 69, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biodegradation, Environmental; Decanoic Acids; Delayed-Action Preparations; Dermatitis, Contact; Dicarboxylic Acids; Drug Carriers; Drug Implants; Female; Mice; Mice, Inbred BALB C; Paclitaxel; Polymers; Ricinoleic Acids

2004
Cutaneous manifestations of Taxol therapy.
    Investigational new drugs, 1995, Volume: 13, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Dermatitis, Contact; Drug Therapy, Combination; Extravasation of Diagnostic and Therapeutic Materials; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Nail Diseases; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel

1995